Acute Chest Syndrome clinical trials

Explore recruiting acute chest syndrome clinical trials.

Recruiting acute chest syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Chest Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TOCIACS : Efficacy and safety of Tocilizumab for acute chest syndrome treatment in paediatric and adult patients with sickle cell disease

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Lidocaine for opioid sparing in vaso-occlusive crisis of Sickle Cell Disease

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

MOOD - MethOxyflurane analgesia in vasoOcclusive crises of sickle cell Disease

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A RANDOMIZED DOUBLE-BLIND PHASE IIA STUDY EVALUATING THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CROVALIMAB AS ADJUNCT TREATMENT IN PREVENTION OF VASO-OCCLUSIVE EPISODES (VOE) IN SICKLE CELL DISEASE (SCD)

Netherlands, Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 / Phase 3, Multicenter, Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled Adaptive Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents with Sickle Cell Disease during Vaso-Occlusive Crisis

Spain, Italy, Greece, Netherlands, Belgium, Germany +1 more

Phase II and Phase III (Integrated) EU CTIS Study details

A multicentre trial evaluating the efficacy and safety of oral decitabine-tetrahydrouridine (NDec) in patients with sickle cell disease

France, Italy, Greece, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Acute Chest Syndrome trials by city

Acute Chest Syndrome in Toronto Acute Chest Syndrome in Vancouver Acute Chest Syndrome in Montreal Acute Chest Syndrome in Calgary Acute Chest Syndrome in Edmonton Acute Chest Syndrome in Ottawa Acute Chest Syndrome in Winnipeg Acute Chest Syndrome in Quebec City Acute Chest Syndrome in Hamilton Acute Chest Syndrome in Kitchener Acute Chest Syndrome in London Acute Chest Syndrome in Halifax Acute Chest Syndrome in New York Acute Chest Syndrome in Los Angeles Acute Chest Syndrome in Chicago Acute Chest Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease